Description

Mechanism of Action

MACULO-Cell™ are mesenchyme-derived stem cells developed by Genkord.

Both local and systemic MACULO-Cell™ applications are predicted to inhibit photoreceptor apoptosis, reduce retinal damage, and prevent corneal scar formation, especially within the eye.

It is expected to have an important place in the treatment or stopping the progression of inflammatory-based diseases, thanks to its neuroprotective-neurodegenerative and anti-inflammatory effects.

Application Method

• Suitable for intra-articular and local injection.
• It is recommended not to apply less than 5 million to each area.
• Application intervals should be at least 3 days.
• It is recommended to apply at intervals of 3 days – 3 weeks.

Recommended to ensure collagen reorganization and accelerate wound healing after tendon surgeries such as connective tissue damage, cruciate ligament repair, patella posterior face, articular cartilage repair (foot, shoulder, knee), Achilles surgery. .